Eight patients who were infected with human immunodeficiency virus, and who
had each sustained an adverse drug reaction while following a regimen incl
uding nevirapine, were switched to a regimen including efavirenz, None of t
he patients experienced adverse events identical to that which necessitated
discontinuation of nevirapine, This study demonstrates that adverse events
related to nevirapine are not a class-specific effect.